Details

Last Funding Type

Seed

Last Funding Money Raised

$200K

Industries

Biotechnology,Pharmaceutical,Therapeutics

Founded date

Jan 1, 2013

Number Of Employee

1 - 10

Operating Status

Active

Theraly is a product focused pharmaceutical company with a goal to efficiently generate medically important, stable, and long-acting therapies. Theraly enables products using its proprietary platform technology that can empower short-acting peptides and proteins by dramatically increasing their half-lives while maintaining potency. Their lead program is a preclinical stage product in development for organ fibrosis. TLY012, has shown therapeutic efficacy in a number of pre-clinical models of organ fibrosis, autoimmune/inflammatory conditions, and in oncology.